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Abstract. 
 
The L1 CAM family of cell adhesion mole-
cules and the ankyrin family of spectrin-binding pro-
teins are candidates to collaborate in transcellular com-
plexes used in diverse contexts in nervous systems of 
vertebrates and invertebrates. This report presents evi-
dence for functional coupling between L1 and 440-kD 
ankyrin
 
B
 
 in premyelinated axons in the mouse nervous 
system. L1 and 440-kD ankyrin
 
B
 
 are colocalized in pre-
myelinated axon tracts in the developing nervous sys-
tem and are both down-regulated after myelination. 
Ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice exhibit a phenotype similar to, 
but more severe, than L1 (
 
2
 
/
 
2
 
) mice and share fea-
tures of human patients with L1 mutations.
 
 
 
Ankyrin
 
B
 
 
(
 
2
 
/
 
2
 
) mice exhibit hypoplasia of the corpus callosum 
and pyramidal tracts, dilated ventricles, and extensive 
degeneration of the optic nerve, and they die by postna-
tal day 21. Ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice have reduced L1 in 
premyelinated axons of long fiber tracts, including the 
corpus callosum, fimbria, and internal capsule in the 
brain, and pyramidal tracts and lateral columns of the 
spinal cord. L1 was evident in the optic nerve at postna-
tal day 1 but disappeared by postnatal day 7 in mutant 
mice while NCAM was unchanged. Optic nerve axons 
of ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice become dilated with diameters 
up to eightfold greater than normal, and they degener-
ated by day 20. These findings provide the first evi-
dence for a role of ankyrin
 
B
 
 in the nervous system and 
support an interaction between 440-kD ankyrin
 
B
 
 and 
L1
 
 
 
that is essential for maintenance of premyelinated 
axons in vivo.
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T
 
he 
 
L1 CAM
 
1
 
 family of cell adhesion molecules
(comprised of L1, NgCAM, NrCAM, CHL1, and
neurofascin) is a major contributor to intercellular
interactions in the vertebrate nervous system (Hortsch,
1996; Brummendorf et al., 1998). L1 CAM molecules,
which are represented in 
 
Drosophila
 
 by neuroglian (Bie-
ber et al., 1989), possess variable extracellular domains
composed of six Ig domains, three to five fibronectin type
III domains, and a relatively conserved cytoplasmic do-
main (Sonderegger and Rathjen, 1992; Hortsch, 1996). Ex-
tracellular domains of L1 CAMs participate in homophilic
interactions as well as a variety of interactions with soluble
proteins and other cell adhesion molecules (Hortsch, 1996;
Brummendorf et al., 1998). Extensive diversity in extracel-
lular interactions of L1 CAM family members is provided
by divergence between extracellular domains encoded by
different genes as well as multiple alternatively spliced
variants of each gene (as many as 50 estimated in the case
of neurofascin) (Hassel et al., 1997). Consistent with the
diverse extracellular domains, a range of functions has
been attributed to the L1 CAM family,
 
 
 
including axon fas-
ciculation, axonal guidance, neurite extension, a role in
long term potentiation, synaptogenesis, and myelination
(Hortsch, 1996; Walsh and Doherty, 1997; Brummendorf
et al., 1998).
Mutations in the human L1 gene, located on the X chro-
mosome, are responsible for mental retardation, as well
as hydrocephalus, abnormal development of major axon
pathways in the corpus callosum and corticocospinal tract,
and motor deficits (Rosenthal et al., 1992; Jouet et al.,
1994; Wong et al., 1995; Fransen et al., 1997). Penetrance
 
Paula Scotland and Daixing Zhou each made major contributions.
Address all correspondence to Vann Bennett, Box 3892, Duke Uni-
versity Medical Center, Durham, NC 27710. Tel.: (919) 684-3538. Fax:
(919) 684-3590. E-mail: benne012@mc.duke.edu
 
1. 
 
Abbreviations used in this paper: 
 
CAM, cell adhesion molecule; DWM,
diffusion-weighted MR microscopy; MR, magnetic resonance.
  
The Journal of Cell Biology, Volume 143, 1998 1306
 
of L1 mutations is variable, except for mental retardation,
which is the most common abnormality. The term CRASH
(corpus callosum agenesis, mental retardation, adducted
thumbs, spastic paraplegia, and hydrocephalus) has been
used to describe general features of L1 mutations (Fran-
sen et al., 1995). Over 35 mutations in L1 have currently
been characterized, and these are distributed in all do-
mains, including several in the cytoplasmic domain (Van
Camp et al., 1996; Fransen et al., 1998
 
a
 
). Disruption of the
L1 gene in mice results in abnormal axon guidance in the
corticospinal tract, brain malformations (including dilated
ventricles), and behavioral deficits (Dahme et al., 1997;
Cohen et al., 1998; Fransen et al., 1998
 
b
 
). These observa-
tions demonstrate the physiological importance of L1 in
normal development of the nervous system as well as a
role of L1 in human disorders.
The cytoplasmic domains of L1 CAM family members
share a conserved sequence that has been demonstrated to
associate with high affinity with ankyrins, a family of spec-
trin-binding proteins located on the cytoplasmic surface
of the plasma membrane (Davis and Bennett, 1994; Dub-
reuil et al., 1996; Garver et al., 1997; Hortsch et al., 1998;
Zhang et al., 1998). The association between ankyrins and
L1 CAMs is regulated by phosphorylation of the FIGQY
tyrosine, a site which is conserved among vertebrate and
invertebrate members of the L1CAM family (Garver et
al., 1997; Tuvia et al., 1997). Ankyrins also associate with
the voltage-gated Na channel, Na/K ATPase, anion chan-
nel, and Na/Ca exchanger. Ankyrins have been proposed
to form lateral complexes between these ion channels and
members of the L1 CAM family (Michaely and Bennett,
1995
 
a
 
,
 
b
 
; Bennett et al., 1997).
The ankyrin family currently includes three genes en-
coding ankyrin
 
R
 
, ankyrin
 
B
 
, and ankyrin
 
G
 
 polypeptides as
well as multiple alternatively spliced variants encoded by
each gene (Peters and Lux, 1993; Bennett et al., 1997).
440-kD ankyrin
 
B
 
 and 480-kD ankyrin
 
G
 
 polypeptides are
the major isoforms in the developing nervous system and
are localized in premyelinated and unmyelinated axons
(Kunimoto et al., 1991; Otto et al., 1991; Chan et al., 1993;
Kunimoto, 1995; Lambert et al., 1997). These axonal
ankyrins have a predicted ball-and-chain configuration,
with an extended tail domain inserted between the COOH-
terminal death domain and globular head domain. The
head domain is composed of membrane- and spectrin-
binding domains (Chan et al., 1993; Kordeli et al., 1995).
The extended tail domains of axonal ankyrins have the po-
tential to interact with cytoskeletal elements, and thus to
couple L1 CAM molecules to cytoplasmic proteins in
addition to the membrane-associated spectrinÐactin net-
work.
L1 CAMs and ankyrins are candidates to collaborate in
a major structural pathway, involving both extracellular
and intracellular interactions, which is used in diverse con-
texts in the developing and adult nervous system. This re-
port presents evidence for functional coupling between
L1 and 440-kD ankyrin
 
B
 
 in premyelinated axon tracts in
the neonatal mouse nervous system. Disruption of the
ankyrin
 
B
 
 gene in the mouse results in a phenotype similar
to, but more severe, than the L1 knock-out in mice and L1
mutations in humans, as well as loss of L1 from premy-
elinated axon tracts. These findings provide evidence that
ankyrins and L1CAMs associate in vivo, and furthermore
identify the genes and alternatively spliced variants in-
volved in L1 CAMÐankyrin interactions in premyelinated
axons.
 
Materials and Methods
 
Gene Targeting
 
A clone containing 17 kb of the 
 
ank2
 
 gene was isolated from a 129SVJ ge-
nomic lambda fix II library using a probe that covers nucleotides 2443Ð
2805 of the human ankyrin
 
B
 
 cDNA. A novel NotI site was introduced
within an exon in the spectrin-binding domain, and this site was used to in-
troduce a cassette that included the neomycin resistance gene (pMC1neo
polyA vector; Stratagene, La Jolla, CA), an in-frame HA epitope, and a
stop codon. An XhoI/HindIII fragment containing the thymidine kinase
gene (from the vector pIC19R) was added to the construct. ES cells were
transfected by electroporation with the linearized targeting construct,
neomycin- and gancycolivir-resistant clones were isolated, and homolo-
gous recombination was verified by Southern blotting (see Fig. 1 
 
B
 
). ES
cells were injected into blastocysts from C57Bl/6 mice and implanted in
C57Bl/6 pseudopregnant mothers. Male chimeric progeny were mated
with C57Bl/6 females to generate heterozygous mice. Homozygous mice
were produced from none-littermate heterozygous mice. ES cell culture,
transfection, and blastocyst injection were performed in the laboratory of
Dr. Beverly Koller (University of North Carolina, Chapel Hill, NC)
 
 
 
(Man-
sour et al., 1988; Koller et al., 1991).
 
Magnetic Resonance Imaging
 
Magnetic resonance (MR) microscopy was performed on a General Elec-
tric (Fremont, CA) 7.1 Tesla unit, 15-cm bore size, equipped with shielded
gradient coils. A Helmholtz coil especially designed for MR microscopy of
fixed specimens at 300 MHz was used for imaging (Banson et al., 1992).
Formalin-fixed brains were suspended in Fomblin (perfluoropolyether;
Ausimont, Inc., Morristown, NJ) to minimize dehydration and to limit
susceptibility effects at the surface. Data was acquired as anisotropic ar-
rays with an aspect ratio of 1:1:2 with the following acquisition parame-
ters: (
 
a
 
) 18.2-h scan time; (
 
b
 
) 20-ms echo time; (
 
c
 
) 1,000-ms repetition
time, diffusion gradient pulse (sine bell-shaped) durations of 5 ms; (
 
d
 
) dif-
fusion gradient separation of 12.2 ms; (
 
e
 
) large diffusion gradients of 35
Gauss/cm, resulting in a diffusion-weighting factor of 965 s/mm
 
2
 
, 256 
 
3
 
256 
 
3 
 
128 digital resolution; and (
 
f
 
) voxel size of 39 
 
3 
 
39 
 
3 
 
78 
 
m
 
m. All im-
ages were analyzed using NIH Image 1.68 (public domain from The Na-
tional Institutes of Health) and VoxelView Ultra (Vital Images, Inc., Fair-
field, IA) for three-dimensional rendering.
 
Analysis of Tissues
 
Immunofluorescence was performed with 5Ð10-
 
m
 
m frozen brain sections,
which were prepared and stained as described (Lambert et al., 1997). Af-
finity-purified rabbit antibodies were raised against the human COOH-
terminal domain (residues 1551Ð1813) and 440-kDÐspecific tail domain
(Chan et al., 1993) of ankyrin
 
B
 
 using recombinant proteins expressed in
bacteria as antigens as described
 
 
 
(Lambert et al., 1997).
 
 
 
Chick antibody
against the 270/480-kD ankyrin
 
G
 
 has been described elsewhere (Lambert
et al., 1997). Rabbit polyclonal antibody against neurofascin was described
in Davis et al. (1996). Antibody against L1 was purchased from Boeh-
ringer Mannheim Corp. (Indianapolis, IN). Electron microscopy was per-
formed with optic nerve fixed with 4% glutaraldehyde and subsequently
embedded in Epon. To determine the sizes of axons in the knock-out and
the control mouse optic nerves, a sheet of paper containing a hole with di-
mensions of 8 
 
3
 
 8 cm was mounted on the electron micrographs, and the
number of axons that appeared in the hole were counted. Northern and
Southern blots
 
 
 
(Sambrook et al., 1989) and immunoblots
 
 
 
(Lambert et al.,
1997) were performed as described. Antibodies used in immunoblotting
experiments are anti-L1, a protein A affinity-purified polyclonal antibody
(a generous gift from Dr. Patricia Manness of the University of North
Carolina at Chapel Hill); polyclonal antispectrin and polyclonal anti-
neurofascin as described in previous reports (Hu et al., 1995; Davis et
al., 1996); and polyclonal anti-NCAM, purchased from Chemicon (Te-
mecula, CA). 
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Results
 
Ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) Mice Exhibit Brain
Malformations Resembling Defects Caused by L1 
Mutations in Humans and Mice
 
The 
 
ank2
 
 gene encoding ankyrin
 
B
 
 was disrupted by ho-
mologous recombination (Fig. 1 
 
A
 
), and ankyrin
 
B
 
 
 
1
 
/
 
1
 
, 
 
1
 
/
 
2
 
,
and 
 
2
 
/
 
2
 
 mice (
 
n
 
 
 
5 
 
325) were identified by Southern blots
(Fig. 1 
 
B
 
) (Materials and Methods). This study is based on
the first-generation progeny with a genetic background of
1:1 129SVJ to C57Bl/6. Brains of ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice ex-
hibited nearly complete loss of a major 13-kb mRNA tran-
script encoding the 440-kD ankyrin
 
B
 
 (Kunimoto et al.,
1991) as well as loss of less abundant 8- and 5-kb tran-
scripts encoding 220- and 150-kD ankyrin
 
B
 
 polypeptides,
respectively (Fig. 1 
 
C
 
). 440- and 220-kD ankyrin
 
B
 
 polypep-
tides were undetectable in homogenates of brains of
ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice by immunoblotting (Fig. 1 
 
D
 
). A mi-
nor 150-kD polypeptide in the ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice still is
barely detectable in original gels, although not in the pub-
lished version. 150-kD ankyrin
 
B
 
 lacks a membrane-bind-
ing domain (Otto et al., 1991). Apparently expression of
the 150-kD ankyrin
 
B 
 
transcript is less affected by disrup-
tion of an exon in the spectrin binding domain (Materials
and Methods).
440-kD ankyrin
 
B
 
 is a major isoform in the early postna-
tal period, as noted previously (Kunimoto et al., 1991).
Ankyrin
 
B
 
 is also expressed in heart where the major iso-
form of 220 kD was undetectable in ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice
(Fig. 1 
 
D
 
).
Ankyrin
 
B
 
 (
 
2
 
/
 
2
 
) mice were born in nearly Mendelian
ratios of 1:3 (81/325), demonstrating normal survival dur-
ing fetal development. However, over half of the ankyrin
 
B
 
(
 
2
 
/
 
2
 
) animals were dead or dying (and therefore killed)
on the first postnatal day, and 95% by 8 d (
 
n
 
 5 
 
81) (Fig. 2
B). A few mutant mice survived until postnatal day 20 (4
out of 81). Mice that did survive to 2 wk were about 25%
of the weight of littermates (n 5 8) and exhibited abnor-
mal locomotion and balance (Fig. 2 A).
Three-dimensional diffusion-weighted magnetic reso-
nance microscopy (DWM) of formalin-fixed brains from a
litter of 1-d-old mice (three mutant and three normal) was
performed to obtain general information on gross mor-
phology and accurate measurements of ventricle volumes.
We used DWM, which measures diffusion of free proton
spins to get optimal anatomical resolution. Brain anatomy
is revealed in detail with DWM because proton diffusion
within regions composed of oriented axon fiber tracts
and those comprised of cell bodies is markedly different
(Beaulieu and Allen, 1996).
Total brain and cerebellar volumes in the ankyrinB (2/2)
brains were nearly identical to those of (1/1) and (1/2)
littermates (Table I). However, volumetric measurements
of the ventricular systems revealed a significant sevenfold
enlargement of the lateral ventricles in the ankyrinB (2/2)
brains compared with controls (Table I; Fig. 3). In addi-
tion, an enlarged lateral ventricle is easily visualized in Fig.
3. Enlargement of lateral ventricles of ankyrinB ( 2/2)
mice was not associated with occlusion of the cerebral aq-
ueduct, which is closed in Fig. 3 but was patent in other
sections (not shown). The extent of lateral ventricle dila-
tion in neonatal ankyrinB (2/2) mice is in agreement with
that reported for some strains of adult L1 (2/2) mice
(Dahme et al., 1997; Fransen et al., 1998b). Fransen et al.
(1998b) found a twofold enlargement of both the fronto-
lateral and fourth ventricle in adult L1 (2/2) mice.
AnkyrinB (2/2) mice did not exhibit fourth ventricle en-
largement; however, they did not survive beyond day 21,
and the full extent of enlargement of brain ventricles could
therefore not be determined. L1 (2/2) mice in some ge-
netic backgrounds do not exhibit enlarged ventricles
(Dahme et al., 1997). Hydrocephalus is also variable in ex-
Figure 1. Generation of ankyrinB (2/2) mice by homologous re-
combination. (A) The strategy for placing the neomycin resis-
tance cassette into an exon of the ank2 gene. The probe for the
Southern blot is indicated. Sites for restriction enzymes, HindIII
(H) and BamHI (B) are indicated. (B) Southern blot demonstrat-
ing homologous recombination using a probe as indicated in A.
The insertion of an extra BamHI site in the targeted locus pro-
duces a band at 4.0 kb. (C) Northern blot with a probe derived
from cDNA encoding the spectrin-binding domain of ankyrinB,
demonstrating loss of ankyrinB transcripts in (2/2) animals. The
amount of total RNA loaded on each lane was indicated by the
18S ribosomal RNA, which was stained with methylene blue. (D)
Immunoblotting of brain and heart homogenate using an anti-
body to the COOH terminus of ankyrinB that recognizes all
known alternatively spliced variants.The Journal of Cell Biology, Volume 143, 1998 1308
tent in humans with L1 mutations, even within the same
kindred (Fransen et al., 1997). L1 hydrocephalus also is as-
sociated with a patent aqueduct of Sylvius in some cases
(Fransen et al., 1995; Wong et al., 1995).
L1 mutations in mice and humans are associated with
abnormalities in the pyramidal tracts and corpus callosum
(Fransen et al., 1997; Cohen et al., 1998). DWM images re-
vealed the presence of the corpus callosum and internal
capsule in sagittal sections as well as pyramidal tracts in
coronal sections in control mice (Fig. 3). The corpus callo-
sum, internal capsule, and pyramidal tracts could not be
resolved in brains of ankyrinB (2/2) mice (Fig. 3). Histo-
logical brain sections also reveal a reduction in the corpus
callosum in ankyrinB ( 2/2) mice, with nearly complete
absence of the anterior portion revealed in a sagittal sec-
tion (Fig. 5). The corpus callosum also was greatly reduced
in coronal sections of ankyrinB mutant brain (Fig. 5). Hy-
poplasia of the corpus callosum was observed in 16/26
(postnatal days 1Ð5) mutant mouse brains examined by
coronal sections. Some of the variability in detection of re-
duction of the corpus callosum may be due to selective loss
of anterior relative to posterior regions.
Loss of L1 in Premyelinated Axon Tracts in the Central 
Nervous System of AnkyrinB (2/2) Mice
The similarities in phenotype of ankyrinB (2/2) mice and
L1 (2/2) mice suggested the possibility that ankyrinB and
Figure 2. Photograph of an ankyrinB (2/2) mouse and a normal
littermate (A) and postnatal survival of ankyrinB (2/2) mice (B).
Animals shown in A were 11 d old. The mutant mouse was 25%
of the weight of the normal animal.
Figure 3. MR microscopy images of brains of normal littermate
and ankyrinB (2/2) mice. Parasagittal of brains from a normal
littermate (EF5 1/1) and an ankyrinB (2/2) mouse are in red
boxes on the right. Sections indicated by blue and green lines are
displayed on the left. Although unmyelinated, the internal cap-
sule and pyramidal tracts are clearly visible in the normal brain
(top left, blue and green panels) and were not evident in the mu-
tant (bottom left, blue and green panels). The internal capsule and
corpus callosum are also visualized in the parasagittal sections of
the normal brain (top right, red panel) and could not be resolved
in the mutant (bottom right, red panel). The lateral ventricles
were abnormally enlarged in mutant brains (bottom left, blue
panel). One ankyrinB (2/2) brain exhibited severe malformation
of most brain structures and is not shown. These images repre-
sent a milder phenotype.
Table I. Volume of Brain Regions by MRM
Parameter
AnkyrinB (2/2)
(n 5 3)
Wild-type
(n 5 3) P value
mm3 mm3
Total brain volume 82 6 10 98 6 10 0.14
Cerebellar volume 4.6 6 0.4 4.9 6 0.4 0.32
Fourth ventricle volume 0.13 6 0.03 0.11 6 0.03 0.36
Lateral ventricle volume 0.20 6 0.07 0.03 6 0.01 0.017Scotland et al. AnkyrinB and L1 Interaction in Premyelinated Axons 1309
L1 are coexpressed in the nervous system. Evidence in
support of segregation of L1 with ankyrinB and of neuro-
fascin with ankyrinG is presented in Fig. 4. Neurofascin has
previously been identified at axon initial segments and
nodes of Ranvier, which are sites that also contain high lo-
cal concentrations of 270/480-kD isoforms of ankyrinG
(Davis et al., 1996; Lambert et al., 1997). Neurofascin and
270/480 ankyrinG are colocalized at axon initial segments
in the neonatal cerebral cortex (Fig. 4). However, in neo-
natal mouse brain, neurofascin and 270/480 ankyrinG were
absent from premyelinated axon tracts, including the cor-
pus callosum (Fig. 4, lower panels) as well the optic nerve
and other sites in the central nervous system (data not
shown). L1 and 440 ankyrinB, in contrast, codistributed in
premyelinated axon fiber tracts in the cerebral cortex (Fig.
4) and throughout the CNS (Figs. 5 and 6).
440-kD ankyrinB and L1 are colocalized in premy-
elinated axons located in long fiber tracts in brain (corpus
callosum, internal capsule, fornix, striatum, and olfactory
tract) (Fig. 5) as well as spinal cord (pyramidal tract
and lateral columns) (Fig. 6). Similar patterns of ankyrinB
staining in axon tracts were observed with antibodies
against the COOH terminus, which react with all known
alternatively spliced forms as with antibodies against 440-
kD ankyrinB (not shown). These patterns of distribution of
L1 are consistent with previous studies (Bartsch et al.,
1989; Joosten and Gribnau, 1989; Martini, 1994). Brain
and spinal cord sections of ankyrinB (2/2) mice exhibited
no staining with antibody against the COOH terminus of
ankyrinB, confirming both the efficacy of gene disruption
and specificity of the antibody.
L1 staining is reduced in premyelinated axon tracts in
brains and spinal cords of ankyrinB (2/2) mice (Figs. 5
and 6). The corpus callosum and internal capsule are re-
duced or absent in mutant animals (Fig. 5) (16/26), as
noted above. However, fiber tracts in the brain that still
were present and exhibited major reduction in L1 staining
include the fimbria and stria terminalis (Fig. 5 A). L1 stain-
ing in the pyramidal tract and lateral columns of the spinal
cord also is greatly reduced (Fig. 6). AnkyrinB (2/2) ani-
mals exhibited variability with respect to L1 staining, with
about 50% having less pronounced differences. For exam-
Figure 4. Codistribution of L1 with ankyrinB in premyelinated axon tracts and codistribution of neurofascin with ankyrinG in axon ini-
tial segments in neonatal mouse brain. The sections through cerebral cortex of neonatal mouse brain were double labeled with antibod-
ies to L1 (A) and ankyrinB (B, composite image shown in C) or antibodies to neurofascin (D and D9) and ankyrinG (E and E9, composite
images shown in F and F9). The results show L1 and ankyrinB codistributed in the axon tracts while neurofascin and ankyrinG colocal-
ized at initial segments of axons. The images shown in D9ÐF9 were taken from the corpus callosum portion of the same section shown in
DÐF. Bars, 10 mm.The Journal of Cell Biology, Volume 143, 1998 1310
ple, L1 staining still is evident in the sagittal section shown
in Fig. 5 B. However, littermate control animals always ex-
hibited strong L1 staining.
Loss of L1 in ankyrinB (2/2) mice is also demonstrated
by immunoblotting of brain tissue (Fig. 7). It was not feasi-
ble to obtain tissue samples from particular anatomical
sites such as corpus callosum or optic nerve (see below),
where loss of L1 is most prominent. Therefore, intact
brains of a control and a mutant postnatal day 7 mouse
were evaluated for levels of L1, neurofascin, NCAM, and
spectrin (n 5 1) (Fig. 7). Expression levels of neurofascin
and NCAM exhibited no detectable change in the brain of
Figure 5. L1 staining is reduced in long fiber tracts in brains of ankyrinB (2/2) mice. Coronal sections of brains close to the optic chiasm
(A) and parasagittal sections (B) of normal littermate (top rows) and ankyrinB (2/2) (bottom rows) mice stained by immunofluores-
cence using an antibody against the ankyrinB COOH terminus cross-reacting with all known ankyrinB polypeptides (left column) and an
antibody against L1 (middle column). The composite staining for both ankyrinB (red) and L1 CAM (green) is in the right column. The
corresponding anterior and posterior portions of corpus callosum in wild-type littermate and the knock-out mice are indicated by the ar-
row and arrowhead, respectively. Similar results were obtained with antibody against the tail domain specific for the 440-kD ankyrinB
(not shown). CC, corpus callosum; Fo, fornix; Fi, fimbria; IC, internal capsule; CPu, caudate putamen; ST, stria medullaris. Bars: (A) 100
mm; (B) 50 mm.Scotland et al. AnkyrinB and L1 Interaction in Premyelinated Axons 1311
the ankyrinB (2/2) mouse. Moreover, levels of bG-spec-
trin also were unchanged (Fig. 7). However, immunoblots
of the same gel samples with antibody against L1 revealed
a 30Ð40% percent reduction in amounts of 200-, 135-, and
43-kD cross-reacting polypeptides (Fig. 7). These results
demonstrating partial loss of L1 are consistent with reduc-
tion of L1 in localized sites detected by immunofluores-
cence.
Loss of L1 staining in ankyrinB (2/2) brain and spinal
cord raises questions of whether lack of ankyrinB impairs
delivery of L1 to axons, whether L1-expressing axon tracts
never form and are simply absent, and/or whether L1-
expressing axons are present initially but subsequently de-
generate. The optic nerve provides a simplified, easily
identifiable anatomical site for addressing issues related to
L1 behavior and axonal degeneration in ankyrinB (2/2)
mice. The premyelinated optic nerve has previously been
identified as a site where the 440-kD ankyrinB is the sole
ankyrin (Chan et al., 1993), and also expresses high levels
of L1 (Bartsch et al., 1989). 440-kD ankyrinB and L1 both
exhibit a dramatic down-regulation coincident with my-
elination and are not expressed in adult myelinated axons
of the optic nerve (Bartsch et al., 1989; Chan et al., 1993).
Transverse sections through optic nerve at postnatal
days 1Ð3 revealed unreduced staining for L1 in ankyrinB
(2/2) mice, even though ankyrinB staining was absent
(n 5 7) (Fig. 8). These observations establish that at least
early in the postnatal period, optic nerve axons are
present, and that L1 is delivered to axons in the absence of
ankyrinB. However, L1 staining disappeared from optic
nerves of ankyrinB (2/2) mice by around postnatal day 7,
although the nerve itself was still present (Fig. 8) (n 5 6).
Optic nerves of normal mice retained L1 and ankyrinB
(Fig. 8). In contrast to L1, levels of NCAM were un-
changed in the optic nerve section of ankyrinB (2/2) mice
at postnatal day 7 (Fig. 8). Neurofascin was only found at
the initial segments of the premyelinated optic nerve ax-
ons and was absent from the optic nerves of both control
and ankyrinB (2/2) mice. Electron micrographs (see be-
low; Fig. 9) reveal that myelination occurred with only a
few axons at this stage and was limited to a few loops of
myelin. The normal loss of L1 accompanying myelination
Figure 6. L1 staining is reduced in the pyramidal tracts and lateral columns in the spinal cords of ankyrinB (2/2) mice. Transverse sec-
tions of spinal cords at thoracic vertebrae 8 of normal littermate (top row) and ankyrinB (2/2) (bottom row) mice were double stained
with an antibody against the ankyrinB COOH terminus cross-reacting with all known ankyrinB polypeptides (left column) and an anti-
body against L1 (middle column). The composite staining for both ankyrinB (red) and L1 CAM (green) is in the right column. PT, py-
ramidal tract; LC, lateral column. Bars, 100 mm.The Journal of Cell Biology, Volume 143, 1998 1312
therefore had not yet begun at the time when L1 disap-
peared from ankyrinB (2/2) optic nerves.
Degeneration of the Optic Nerve in
AnkyrinB (2/2) Mice
Electron microscopy of transverse sections of the postna-
tal day 1 optic nerve revealed relatively normal axon pro-
files in ankyrinB (2/2) mice, although the average axon
cross-sectional area was increased about 20% (see Materi-
als and Methods; data not shown). Axons were packed in
tightly assembled arrays, indicating that some level of
axon fasciculation occurs in the absence of ankyrinB. Sec-
tions of postnatal day 9 optic nerve reveal a major change
in axons of ankyrinB ( 2/2) mice (Fig. 9). Many axons
were increased in diameter up to eightfold compared with
the normal axon and contained multivescicular bodies.
Longitudinal sections demonstrated increased diameter
along the length of ankyrinB ( 2/2) axons (not shown).
Axon fasciculation also was impaired in sections of an-
kyrinB (2/2) optic nerve with many examples of loss of di-
rect axonÐaxon contacts (Fig. 9).
All ankyrinB (2/2) mice surviving until postnatal day 21
exhibited nearly complete degeneration of the optic nerve
(n 5 8) (Fig. 10). The optic nerve of ankyrinB (2/2) mice
thus forms initially with normal axonal delivery of L1 and
subsequently degenerates. AnkyrinB and ankyrinG are co-
expressed before myelination in most other nerves, includ-
ing the trigeminal nerve (Lambert et al., 1997). The optic
nerve, which only has ankyrinB, apparently is especially
vulnerable in ankyrinB (2/2) mice.
Discussion
This study describes dramatic consequences of deficiency
of ankyrinB in mice that allow survival until birth but re-
sult in hypoplasia of the corpus callosum and pyramidal
tracts, dilated lateral ventricles, followed by extensive de-
generation of the optic nerve, and death by postnatal day
21. This phenotype is similar to, but more severe, than
those observed in L1 (2/2) mice and human patients with
L1 mutations. L1 was reduced or absent in ankyrinB (2/2)
mutant mice in premyelinated axons of long fiber tracts in
the brain and spinal cord as well as optic nerve at postnatal
day 7. These findings provide the first evidence for a role
of ankyrinB in the vertebrate nervous system and support
a functional connection between ankyrinB and L1 that is
required for maintenance of premyelinated axons in vivo.
L1 deficiency in mice is compatible with survival to
adulthood (Dahme et al., 1997; Cohen et al., 1998; Fransen
et al., 1998b) and represents a much less severe phenotype
than ankyrinB deficiency. Other L1 CAM family members
(CHL1, NrCAM, NgCAM, and neurofascin) may func-
tionally compensate for L1 in L1 (2/2) mice. In addition,
ankyrinB is likely to have additional roles unrelated to L1,
particularly early in development when some L1 CAMs
are tyrosine phosphorylated and therefore incapable of
binding to ankyrin (Garver et al., 1997; Zisch et al., 1997;
Heiland et al., 1998). Conversely, L1 and other members
of the family are likely to have ankyrin-independent func-
tions when these proteins are tyrosine phosphorylated.
This study demonstrates that early in development, L1 is
capable of axonal transport to the optic nerves of ankyrinB
(2/2) mice, implying that its delivery to the plasma mem-
brane and axonal targeting are independent of ankyrinB. It
will be of interest to determine the phosphorylation state
of L1 in the early postnatal optic nerve, where this protein
is transported to axons in the absence of ankyrinB (Fig. 6).
The mechanism for loss of L1 in ankyrinB (2/2) axons
is not known, but it could result from reduced stability of
L1 in the absence of ankyrinB. A similar situation in which
loss of a cytoskeletal protein results in reduction of inte-
gral proteins has been found in mdx mice, where absence
of dystrophin results in reduction of dystrophin-associated
proteins (Matsumura et al., 1992). A practical consequence
of reduced expression of interacting proteins is that a char-
acterization of patterns of gene or protein expression in
the ankyrinB (2/2) mouse brain may yield heretofore uni-
dentified proteins whose functions involve ankyrinB.
The striking increase in axonal diameter of optic nerve
axons suggests the hypothesis that the absence of ankyrinB
leads to loss of mechanical stability of axons. AnkyrinB
could contribute to axonal membrane support by connect-
ing the spectrinÐactin network to the plasma membrane,
as occurs in erythrocytes (Peters and Lux, 1993). In this
case, axonal swelling would be analogous to hereditary
Figure 7. Immunoblots of neurofascin, NCAM, bG spectrin, and
L1 in brain tissue from ankyrinB (1/1) and (2/2) mice. Polypep-
tides in total brain homogenates of an ankyrinB mouse (2/2) (left
lanes) and a (1/1) littermate (right lanes) mouse were separated
on a 3.5Ð17.5% SDSÐpolyacrylamide gel and either stained with
Coomassie blue or transferred to a nitrocellulose membrane. Du-
plicate membranes were blotted with polyclonal antibodies to
ankyrinB (ankB), spectrin (spec), neurofascin (Nf), NCAM, and
L1, and bound antibodies were detected with 125I-labeled protein
A. L1 polypeptides of 200, 135, and 43 kD are marked on the left.
The extent of labeling was quantitated by a phosphoimager. Im-
munoblots were scanned to a phosphoimager and analyzed using
ImageQuant software developed by Molecular Dynamics
(Sunnyvale, CA). Compared with the wild-type littermate, L1
polypeptides of 200, 135, and 43 kD were reduced by 38, 29, and
27%, respectively, in ankyrinB (2/2) brain samples. The relative
amounts of spectrin, neurofascin, and NCAM in the ankyrinB
(2/2) samples were 0.95, 1.01, and 1.06 that of wild-type sam-
ples, respectively.Scotland et al. AnkyrinB and L1 Interaction in Premyelinated Axons 1313
spherocytosis of erythrocytes observed in cases of an-
kyrinR mutations (Eber et al., 1996). The tail domain of
the 440-kD ankyrinB potentially could extend several hun-
dred nanometers into the axoplasm and also mediate in-
teractions with structural proteins in addition to the spec-
trin skeleton. L1-mediated connections between axons
combined with coupling to the spectrinÐactin network via
ankyrin could provide an additional level of mechanical
Figure 8. L1 is initially expressed and subsequently lost in premyelinated optic nerves of ankyrinB (2/2) mice. Transverse sections
through the optic nerves of postnatal day 1 mice (P1) and day 7 mice (P7) were double stained with antibodies against ankyrinB COOH
terminus (top row) and L1 (middle row). The P7 optic nerve sections also were double stained with antibodies to NCAM (right top pan-
els) and L1 (right middle panels). The composite images for both ankyrinB (red) and L1 CAM (green) or NCAM (red) and L1 (green)
were shown in the bottom row. The genotype of the mice was marked with 2/2 for the knock-out mouse and WT for the wild-type
mouse. Bars, 10 mm.
Figure 9. Electron micro-
graphs of transverse sections
of optic nerves of day 1 (top
row) and day 9 (bottom row)
normal mice (right) and
ankyrinB ( 2/2) mice (left).
Sections of optic nerves were
obtained within 1 mm of the
optic chiasm and matched as
closely as possible between
mutant and control animals.
Several dilated axons are out-
lined between the two arrow-
heads. Arrows denote sites
where axons are not in con-
tact with each other. A
mulivescicular body in a day
9 mutant axon is marked by
an asterisk. Bar, 1 mm.The Journal of Cell Biology, Volume 143, 1998 1314
support for axon bundles. Such a transcellular network
based on L1 and ankyrin is analogous, in a formal sense, to
the epidermis, where keratinocytes are connected through
desmosomes on their outer surfaces, and desmosomes
are interconnected via intermediate filaments. The conse-
quence in both cases is a mechanical buffering system ca-
pable of distributing shear stresses throughout the tissue.
It is of interest in this regard that the brains of ankyrinB
(2/2) are much more fragile and susceptible to damage
during dissection compared with brains of normal mice
(data not shown).
AnkyrinB and L1 are coexpressed and may interact at
sites in addition to premyelinated axons. Unmyelinated
axons in the molecular layer of the adult cerebellum ex-
press 440-kD ankyrinB as well as L1 (Kunimoto et al.,
1991; Martini, 1994; Kunimoto, 1995). 220-kD ankyrinB is
expressed in glial cells, including Schwann cells and astro-
cytes (Kordeli et al., 1990; Kunimoto et al., 1991; Kuni-
moto, 1995), and could associate with alternatively spliced
forms of L1 present in these cells (Martini, 1994). L1 is ex-
pressed outside of the nervous system in cells including
lymphocytes (Kowitz et al., 1992). It will be of interest in
future experiments to examine L1 distribution and func-
tion in ankyrinB (2/2) mice at sites of axoÐglial contact
and in the immune system.
Ankyrin and L1 have both been implicated in axon
guidance. L1-deficient mice exhibit defects in guidance of
corticospinal axons across the pyramidal decussation (Co-
hen et al., 1998). Ankyrin (Unc-44) mutations in Cae-
norhabditis elegans result in abnormal axon outgrowth and
guidance (Otsuka et al., 1995). It is not clear from the cur-
rent data if ankyrinB and L1 collaborate in axonal guid-
ance, or if ankyrinB has any role in axonal guidance. It will
be of interest to trace the paths of axons in the optic nerve
and corticospinal tracts of ankyrinB (2/2) mice to deter-
mine possible defects in decussation and in final arrival at
neuronal targets. Consequences of ankyrinB deficiency, in-
cluding degeneration of the optic nerve, could be second-
ary to defective targeting of axons to their normal sites ac-
companied by apoptosis caused by lack of retrograde
transport of appropriate factors.
The accumulated L1 mutations characterized in human
families provide a valuable database for structureÐfunc-
tion studies of the L1 molecule (Fransen et al., 1998a).
One missense mutation in the L1 cytoplasmic domain re-
sults in conversion of Y1229 to H and clinical disease (Van
Camp et al., 1996). The Y1229H mutation of the FIGQY
tyrosine is of particular interest with respect to ankyrin.
Recent analysis of structural requirements for L1 CAM
binding to ankyrin has demonstrated that the FIGQY ty-
rosine is essential for ankyrin binding (Hortsch et al., 1998;
Zhang et al., 1998). Moreover, mutation of the FIGQY ty-
rosine to histidine abolishes ankyrin binding activity of
neurofascin (Zhang et al., 1998). These considerations sug-
gest the possibility that ankyrin binding activity of L1 is
also abolished by the Y1229H mutation, and that loss of
ankyrin binding results in loss of L1 function in humans.
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